Zevra Therapeutics Inc (ZVRA)

SG&A Expense Growth

-20.32%

Quarterly · Period ending:

ZVRA logo

ZVRA SG&A Expense Growth

Latest reported-20.32%
ZVRA Quarterly SG&A Growth (QoQ) (0.00% → -20.32%)
High-resolution chart · PNG

ZVRA sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-20.3243%
2.1077%
20.189%
-18.5112%
6.329%
21.2093%
-0.5121%
28.5941%
26.9157%
-32.244%
151.9251%
-12.0085%
-8.5098%
42.3478%
27.7554%
11.692%
30.139%
6.964%
31.2115%
-15.4881%
21.8288%
-25.1582%
76.9069%
-16.8703%
-23.4298%
63.1541%
-61.9153%
20.8765%
5.3206%
-4.251%
-0.9358%
-12.5146%
9.1954%
19.8164%
-21.2413%
-7.1349%
9.4305%
13.4816%
-52.9277%
42.6172%
14.7484%
45.5963%
19.2379%
-32.4969%
226.305%
-38.0506%
45.2203%
-18.3459%
149.0637%
21.5277%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.